SCHEMBL5326606

SCHEMBL5326606

NC(CCc1cccc2[nH]ccc12)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.52
MAPT P10636 3/20 0.52
LMNA P02545 2/20 0.52
TSHR P16473 2/20 0.52
BLM P54132 2/20 0.52
PMP22 Q01453 2/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
MPO P05164 1/20 0.52
HIF1A Q16665 1/20 0.52
GRIK1 P39086 1/20 0.44
GRIA1 P42261 1/20 0.44
GRIA2 P42262 1/20 0.44
GRIA3 P42263 1/20 0.44
GRIA4 P48058 1/20 0.44
GRIK2 Q13002 1/20 0.44
GRIK3 Q13003 1/20 0.44
PARP1 P09874 1/20 0.43
GLS O94925 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1052199 0.85 MAPT (0.67) KDM4EMAPTLMNATSHRBLM
SCHEMBL30528867 0.85 MAPT (0.67) KDM4EMAPTLMNATSHRBLM
SCHEMBL1052201 0.85 MAPT (0.67) KDM4EMAPTLMNATSHRBLM
Hydrochloric Acid SCHEMBL20513716 0.84 MAPT (0.65) KDM4EMAPTLMNATSHRBLM
Hydrochloric Acid SCHEMBL20513717 0.84 MAPT (0.65) KDM4EMAPTLMNATSHRBLM
SCHEMBL29414366 0.81 MAPT (0.74) KDM4EMAPTLMNATSHRBLM
SCHEMBL27426182 0.81 MAPT (0.74) KDM4EMAPTLMNATSHRBLM
SCHEMBL1769610 0.81 MAPT (0.74) KDM4EMAPTLMNATSHRBLM
SCHEMBL1769607 0.81 MAPT (0.74) KDM4EMAPTLMNATSHRBLM
SCHEMBL31688500 0.81 GRIK1 (0.48) KDM4EMAPTLMNATSHRBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070258899-A1 Diagnostic and therapeutic agents KARYON-CTT LTD (FI) 2007-11-08 US disclosed
WO-2007113385-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS KARYON-CTT LTD (FI) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258899-A1 Diagnostic and therapeutic agents YBX1, MLX, TPX2 KDM4E 2053/4885MAPT 3794/4885LMNA 3163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.